What is Circio Holding ASA (CRNA.OL)?

Circio Holding ASA (CRNA.OL) is a stock in the Healthcare sector, Biotechnology industry. View full analysis on Stocks360.

Circio Holding ASA (CRNA.OL)

Stock analysis · OSL · Healthcare · Biotechnology

Market Cap

N/A

PE (TTM)

N/A

EPS (TTM)

N/A

Dividend Yield

N/A

Beta

-1.11

Day Range

N/A

52-wk Range

N/A

Avg Volume

N/A

Volume

N/A

Circio Holding ASA (CRNA.OL) is a publicly traded company in the Healthcare sector. Sign in to Stocks360 for full DCF valuation, fundamentals, technicals, and AI-driven analysis.

Get full analysis → Short-Term Analysis →

Earnings

Most Recent

May 11, 2023

EPS $-0.28 vs est. $-0.20

Missed by $0.08

Proprietary Signals

Signal snapshot temporarily unavailable.

About Circio Holding ASA

Circio Holding ASA, a biotechnology firm based in Oslo, Norway, and founded in 2010, specializes in the development of advanced circular RNA and immunotherapy treatments. Among its key innovations is TG01, a cancer vaccine aimed at specific driver mutations, which is currently progressing through three clinical trials for indications including multiple myeloma, pancreatic cancer, and lung cancer. The company also pioneers the circVec circRNA vector platform, an adaptable genetic module designed to facilitate the creation of diverse functional circular RNAs within human cells. This circVec platform is further supported by a collaborative agreement with Certest Biotec, S.L., focusing on its formulation. Formerly known as Targovax ASA, the company officially rebranded to Circio Holding ASA in May 2023.